Go to the list of all blogs
Anna G's Avatar
published in Blogs
Oct 15, 2023

Medical Distributors Surge: $CAH, $ZYXI, $PDCO, $COR, $MCK Gain +3.18%

Medical Distributors Surge: A Deeper Dive into Market Movements and Notable Tickers

πŸ“ˆ Medical Distributors experience a +3.18% gain in the past month. Current Buy/Sell Ratings suggest a Positive Outlook for stocks in the group.

Are you interested in the dynamic world of medical distributors and eager to optimize your trading strategies within this sector? Look no further! Our AI robots are tailored to meet your trading needs in the Group Medical Distributors arena.

πŸ€– "Swing Trader, Popular Stocks: Price Action Trading Strategy (TA&FA)" provides you with a reliable and data-driven approach to trading within this sector. Whether you're a seasoned trader or just starting, this AI tool can assist you in making informed decisions.

πŸ’Ό For those seeking to capitalize on upward market trends, "Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA)" offers a simplified yet effective strategy. It's designed to empower traders to navigate and thrive in markets on the rise.

With these AI robots by your side, you'll be well-equipped to explore trading opportunities and make data-backed decisions in the ever-evolving world of medical distributors. Elevate your trading game today!

Tickers in this Group:Β 
$EDAPΒ - $CAHΒ - $MCKΒ - $CORΒ -Β $HSICΒ -Β  $OMIΒ -Β $PDCOΒ - $ZYXI

The Landscape of Medical Distributors

Medical distributors play a pivotal role in the healthcare ecosystem, bridging the gap between manufacturers and providers. Their core services, ranging from product distribution to inventory management, contribute significantly to the US healthcare sector's value. As per a report by Deloitte, these services infuse a value of $33 billion-$53 billion annually. Major players in this sector include giants like McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc., and Patterson Companies, Inc.

Market Cap: The Financial Magnitude

The medical distributors' industry has a collective market cap averaging at 8.9B. The spectrum is vast - from $MCK at a towering 61.9B to a modest $SNYR at 494.4K.

High and Low Price Notable News: The Peaks and Valleys

  • Average weekly price growth: 2.39%
  • Average monthly price growth: 2.09%
  • Quarterly spike: 11.3%

Key Players:

  • $EXHID soars with the highest growth at 37.25%
  • $OMI takes a dip at -4.39%

Recent News Highlights:

  • 10/11/23: $CAH leaps with a +5.51% weekly increase.
  • 8/18/23: Both $OMI and $CAH saw declines, dropping by -14.46% and -6.44%, respectively.

Volume: The Trading Buzz

  • Weekly volume decline: -7.21%
  • Monthly volume decline: -56.61%
  • Quarterly volume increment: 0.2%

Fundamental Analysis Ratings: The Deep Dive

  • Valuation Rating: 66
  • P/E Growth Rating: 51
  • Price Growth Rating: 56
  • SMR Rating: 66
  • Profit Risk Rating: 73
  • Seasonality Score: 27 (Scale: -100 to +100)

Ticker Descriptions: Highlighting Key Players

πŸ” $CAH: Now trending upward after rising above its 50-day MA on October 04, 2023. Past trends suggest a 78% chance of continued uptrend.

πŸ” $ZYXI: Watch out! Entering the oversold zone as of October 13, 2023. Historically, it indicates potential for a price uptrend or consolidation soon.

πŸ” $PDCO: Positive vibes! MACD Histogram turned positive on September 21, 2023, with 82% chances of a continued rise.

πŸ” $COR: Bullish trend with the 10-day MA crossing over the 50-day MA on September 28, 2023. Past data indicates a 71% chance of continued upward movement.

πŸ” $MCK: Yet another MACD positive shift on September 12, 2023, with a strong 75% odds of maintaining the bullish trend.

πŸ” $EDAP: Positive MACD crossover on September 20, 2023, suggests an 84% probability of an upward trend in the coming month.

Β 

The Medical Distributors sector is currently buzzing with positive vibes, reflected in its impressive gains and overall positive outlook. Traders should closely monitor the described tickers and watch for further market shifts. As always, it's essential to make informed decisions and keep an eye on these notable market movers. Happy trading! πŸ“ŠπŸ“‰πŸ“ˆ

Related Ticker: FOCL, CAH, MCK, COR, HSIC, OMI, PDCO, ZYXI

FOCL's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for FOCL turned positive on June 17, 2026. Looking at past instances where FOCL's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 16, 2026. You may want to consider a long position or call options on FOCL as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FOCL advanced for three days, in of 241 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 183 cases where FOCL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 15 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

FOCL broke above its upper Bollinger Band on June 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FOCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (18.182) is normal, around the industry mean (19.710). P/E Ratio (0.000) is within average values for comparable stocks, (42.672). FOCL's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.308). FOCL's Dividend Yield (0.000) is considerably lower than the industry average of (0.007). P/S Ratio (2.478) is also within normal values, averaging (5.990).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FOCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 18.13B. The market cap for tickers in the group ranges from 557.05K to 92.06B. MCK holds the highest valuation in this group at 92.06B. The lowest valued company is CNBI at 557.05K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was 10%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was -0%. COSM experienced the highest price growth at 28%, while EMPG experienced the biggest fall at 0%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was 96%. For the same stocks of the Industry, the average monthly volume growth was 66% and the average quarterly volume growth was 201%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 61
Price Growth Rating: 54
SMR Rating: 89
Profit Risk Rating: 78
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
FOCL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of minimally invasive medical devices for urological diseases

Industry MedicalDistributors

Profile
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interact to see
Advertisement
TSM shares have remained relatively resilient despite heightened volatility, supported by the ongoing global buildout of AI infrastructure. Investor attention has centered on capacity expansion updates and signals from major customers, particularly in high-performance computing. While execution risks remain in the near term, leadership in advanced manufacturing and packaging continues to anchor TSM’s long-term growth narrative, even as global supply chains face scrutiny.
Rivian (RIVN) is carving out a distinct position in the electric vehicle market by targeting adventure-focused consumers, commercial fleets, and long-term sustainable transportation solutions. As the EV industry moves beyond early adoption toward scalability and efficiency, Rivian is emphasizing broader product offerings, streamlined manufacturing, and software-enabled services.
Aon plc (AON) reported third-quarter 2025 revenue of $3.997 billion, representing a 7% year-over-year increase with equal organic growth. Adjusted earnings per share came in at $3.05, exceeding expectations. In late November, Moody’s reaffirmed Aon’s Baa2 credit rating and revised the outlook to positive, citing reduced leverage following the NFP acquisition.
General Motors (GM) is in the midst of a long-term transformation, evolving from a traditional automotive manufacturer into a technology-focused mobility company. By combining its global scale, manufacturing capabilities, and well-known brands, GM is accelerating its push into electric vehicles, software-defined platforms, and autonomous systems, while continuing to generate cash from its internal-combustion portfolio.
Air Products and Chemicals, Inc. (APD) entered the spotlight after announcing advanced discussions with Yara International on December 8 to collaborate on low-emission ammonia projects. While the strategic direction aligns with global decarbonization trends, uncertainty around execution and capital requirements triggered a 9.45% one-day decline in the stock.
APO shares have traded in a relatively tight range recently, consolidating near the $148 level. The stock reflects investor confidence in Apollo’s expanding asset base, record fee earnings, and disciplined execution amid renewed interest in alternative assets. Growth in retirement services through Athene continues to provide stability, helping offset volatility across private equity and credit markets.
Lockheed Martin and RTX Corporation are two of the most prominent names in the aerospace and defense industry, both positioned to benefit from heightened global security concerns and sustained U.S. military spending.
Eli Lilly and Novo Nordisk are among the most influential pharmaceutical companies in the rapidly expanding GLP-1 receptor agonist market, which targets diabetes and obesity. As competition intensifies and regulatory and pricing dynamics evolve, the divergence in their stock performance has become increasingly pronounced.
Lumentum and Ciena are leading players in the optical networking sector, positioned to capitalize on surging demand for high-speed data transmission driven by AI, cloud computing, and 5G rollouts. Their business models, however, diverge significantly: LITE focuses on specialized photonic components, while CIEN offers broader networking solutions.
As 2025 winds down, the Savings Banks sector reflects a mix of stability, innovation, and AI-driven disruption. Among the most closely watched tickersβ€”SOFI Technologies (SOFI), Ally Financial (ALLY), and PayPal Holdings (PYPL)β€”investors have witnessed contrasting stories of growth, valuation, and market perception.
As 2025 comes to a close, financial markets remain dynamic, with technology and entertainment stocks capturing investor attention. Streaming platforms, in particular, are navigating content consolidation, evolving consumer preferences, and digital monetization shifts. Netflix (NFLX), Disney (DIS), and Spotify (SPOT) stand out as major players at the intersection of streaming, entertainment, and technology.
Ondas Holdings (ONDS) is a wireless technology company focused on delivering secure, long-range communications for industrial Internet of Things (IoT) and data networking applications. Its solutions are built to support mission-critical operations across sectors such as rail, energy, maritime, infrastructure, and industrial automation.
Ciena’s growth is driven by expanding offerings in optical networking, network automation software, and 5G transport infrastructure, complemented by services designed to help customers modernize and future-proof their networks. Its evolving technology portfolio addresses the rising complexity, speed, and reliability requirements of today’s communications environment.
Marathon Digital Holdings (MARA) and Riot Platforms (RIOT) are two leading companies in the Bitcoin mining industry, each operating energy-intensive infrastructure to capitalize on cryptocurrency market cycles. This comparison is especially relevant amid ongoing Bitcoin price volatility and growing interest in digital assets and AI-related infrastructure.
Roivant Sciences has delivered strong year-to-date performance, with shares up roughly 82%, driven by encouraging pipeline developments and increased investment in high-potential subsidiaries such as Immunovant.
MP Materials Corp. (MP) and USA Rare Earth, Inc. (USAR) are central to the United States’ push to establish a secure, domestic supply of rare earth elementsβ€”materials critical to electric vehicles, renewable energy, and defense technologies. As geopolitical tensions and supply chain vulnerabilities intensify, these two companies offer distinct approaches to addressing U.S. dependence on foreign sources.
SanDisk (SNDK) Corporation has emerged as one of the strongest performers in the semiconductor storage space, benefiting from its central role in AI infrastructure buildouts. The stock has risen more than fivefold from recent cycle lows, fueled by accelerating demand for high-capacity NAND flash and solid-state drives essential for data-intensive workloads.
As markets move into 2026, the outlook for SPY remains cautiously optimistic. Technical momentum, investor sentiment, and AI-driven forecasts align in favor of continued upside, assuming macroeconomic conditions remain stable and Federal Reserve policy evolves as expected.
Over the past year, the Direxion Daily Semiconductor Bull 3X Shares ETF (SOXL) has stood out as one of the market’s most volatileβ€”and potentially rewardingβ€”leveraged ETFs. Designed to deliver three times the daily performance of the ICE Semiconductor Index, SOXL closely tracks the heartbeat of the semiconductor industry, a sector at the core of global digital and AI transformation.